Polypill for the treatment of cardiovascular diseases

Mechanistic explanation to the catalysis by pyrazinamide and ethambutol of reaction between rifampicin and isoniazid in anti-TB FDCs

Hemant Bhutani, Saranjit Singh, K.C. Jindal et al. · Journal of Pharmaceutical and Biomedical Analysis · 2005 · 60 citations

Pharmacy, Chemistry, Pharmacology +9

On the selectivity of acylation of unprotected diamino acids

Jean Claude Leclerc, Léo Benoiton · Canadian Journal of Chemistry · 1968 · 42 citations · Full text

Natural Sciences, Biochemistry, Chemistry +8

Development and validation of a stability indicating HPLC method for determination of lisinopril, lisinopril degradation product and parabens in the lisinopril extemporaneous formulation

Christopher A. Beasley, Jessica Shaw, Zack Zhao et al. · Journal of Pharmaceutical and Biomedical Analysis · 2004 · 40 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16

Drug-Drug Interaction Studies on First-Line Anti-tuberculosis Drugs

Hemant Bhutani, Saranjit Singh, K.C. Jindal · Pharmaceutical Development and Technology · 2005 · 35 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +15

LC and LC–MS methods for the investigation of polypills for the treatment of cardiovascular diseases

Vijay Kumar, Ravi P. Shah, Saranjit Singh · Journal of Pharmaceutical and Biomedical Analysis · 2008 · 25 citations

Medicine, Cardiology, Pharmacology +10